Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Joseph J, Carter"'
Autor:
Claire Buchta Rosean, Erica C. Leyder, Jeneice Hamilton, Joseph J. Carter, Denise A. Galloway, David M. Koelle, Paul Nghiem, Teri Heiland
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionMost cases of Merkel cell carcinoma (MCC), a rare and highly aggressive type of neuroendocrine skin cancer, are associated with Merkel cell polyomavirus (MCPyV) infection. MCPyV integrates into the host genome, resulting in expression of
Externí odkaz:
https://doaj.org/article/6826851a63ae444b9426a08543e37702
Publikováno v:
Vaccines, Vol 10, Iss 6, p 837 (2022)
Infection with human papillomavirus (HPV) is the necessary cause of cervical cancer. Availability of vaccines against HPV makes it a highly preventable disease. HPV vaccines act through type-specific neutralizing antibodies produced by antigen-specif
Externí odkaz:
https://doaj.org/article/3799f7bee79546af84377183f2c571cd
Autor:
Denise A. Galloway, Paul Nghiem, Margaret M. Madeleine, Juergen C. Becker, David Schrama, Jayasri G. Iyer, Kevin W. Cahill, Lisa G. Johnson, Joseph J. Carter, Kelly G. Paulson
Supplementary Figures 1-2, Methods from Antibodies to Merkel Cell Polyomavirus T Antigen Oncoproteins Reflect Tumor Burden in Merkel Cell Carcinoma Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68d6e52ef3faba4affdece5a90723d46
https://doi.org/10.1158/0008-5472.22386551
https://doi.org/10.1158/0008-5472.22386551
Autor:
Erin M. Scherer, Robin A. Smith, Daniel F. Gallego, Joseph J. Carter, Gregory C. Wipf, Manuela Hoyos, Michael Stern, Tate Thurston, Nathan D. Trinklein, Anna Wald, Denise A. Galloway
Publikováno v:
EBioMedicine, Vol 10, Iss C, Pp 55-64 (2016)
Although licensed human papillomavirus (HPV) vaccines are most efficacious in persons never infected with HPV, they also reduce infection and disease in previously infected subjects, indicating natural immunity is not entirely protective against HPV
Externí odkaz:
https://doaj.org/article/8c2fc8d36a664cfbb10051c22baf9d62
Autor:
Erin M Scherer, Robin A Smith, Cassandra A Simonich, Nixon Niyonzima, Joseph J Carter, Denise A Galloway
Publikováno v:
PLoS Pathogens, Vol 10, Iss 10, p e1004461 (2014)
Licensed human papillomavirus (HPV) vaccines provide near complete protection against the types of HPV that most commonly cause anogenital and oropharyngeal cancers (HPV 16 and 18) when administered to individuals naive to these types. These vaccines
Externí odkaz:
https://doaj.org/article/d78eb0b28db64075a3e786103cd8617a
Autor:
Joseph J. Carter, Robert Nathan Link, Leandra Krowsoski, Michael J. Klein, H. Pachter, Cherisse Berry, Amit Uppal, Manish Parikh, Manish Tandon, Steven M. Cohen, Marko Bukur, Spiros G. Frangos
Publikováno v:
Annals of Surgery
Autor:
Aaron Seese, Erin M. Scherer, Kristen W. Cohen, Andrew T. McGuire, Joseph J. Carter, Sarah Ameny, M. Juliana McElrath, Abigail Wall, Denise A. Galloway, David J. Rawlings, Rachael E. Whaley, Tanvi Arkatkar, Iram F. Khan
Publikováno v:
Journal of Immunological Methods
The isolation of human monoclonal antibodies (mAbs) arising from natural infection with human pathogens has proven to be a powerful technology, facilitating the understanding of the host response to infection at a molecular level. mAbs can reveal sit
Autor:
Anna Wald, Robin A. Smith, Gregory C. Wipf, Daniel F. Gallego, Denise A. Galloway, Joseph J. Carter, Michael Stern, Erin M. Scherer
Publikováno v:
The Journal of Infectious Diseases
High levels of human papillomavirus vaccine–elicited neutralizing serum antibodies elicited to the first and second doses strongly correlated with reduced memory B-cell responses to the third dose, including antibody responses.
Current guidanc
Current guidanc
Autor:
Deborah I. Ritter, Ata S. Moshiri, Mark H. Wener, Masaoki Kawasumi, Jayasri G. Iyer, Aaron Lisberg, Erica S. Tarabadkar, William T. Simonson, Lola Mudgistratova, C. Lewis, Chihiro Morishima, Joseph J. Carter, Kelly G. Paulson, Astrid Blom, Paul Nghiem, Denise A. Galloway, Kathleen Hutchinson, Shailender Bhatia, Mary W. Redman
Publikováno v:
Cancer. 123:1464-1474
BACKGROUND Merkel cell carcinoma (MCC) is an aggressive skin cancer with a recurrence rate of >40%. Of the 2000 MCC cases per year in the United States, most are caused by the Merkel cell polyomavirus (MCPyV). Antibodies to MCPyV oncoprotein (T-antig
Autor:
Qinghua Feng, Denise A. Galloway, Laura A. Koutsky, Tsung Chieh Jane Fu, Joseph J. Carter, Stephen M. Schwartz, Taylor Lasof, Long Fu Xi, James P. Hughes, Rachel L. Winer, Joshua E. Stern, Stephen E. Hawes
Publikováno v:
International Journal of Cancer. 139:2201-2212
To understand high-risk (hr) human papillomavirus (HPV) epidemiology in mid-adulthood, we assessed whether associations between incident detection of hrHPV DNA and recent sexual behavior differed according to whether or not there was serologic eviden